1rew: Difference between revisions

New page: left|200px<br /> <applet load="1rew" size="450" color="white" frame="true" align="right" spinBox="true" caption="1rew, resolution 1.863Å" /> '''Structural refinem...
 
No edit summary
Line 1: Line 1:
[[Image:1rew.gif|left|200px]]<br />
[[Image:1rew.gif|left|200px]]<br /><applet load="1rew" size="350" color="white" frame="true" align="right" spinBox="true"  
<applet load="1rew" size="450" color="white" frame="true" align="right" spinBox="true"  
caption="1rew, resolution 1.863&Aring;" />
caption="1rew, resolution 1.863&Aring;" />
'''Structural refinement of the complex of bone morphogenetic protein 2 and its type IA receptor'''<br />
'''Structural refinement of the complex of bone morphogenetic protein 2 and its type IA receptor'''<br />


==Overview==
==Overview==
Bone morphogenetic protein-2 (BMP-2) and other members of the TGF-beta, superfamily regulate the development, maintenance and regeneration of, tissues and organs. Binding epitopes for these extracellular signaling, proteins have been defined, but hot spots specifying binding affinity and, specificity have so far not been identified. In this study, mutational and, structural analyses show that epitopes of BMP-2 and the BRIA receptor form, a new type of protein-protein interface. The main chain atoms of Leu 51, and Asp53 of BMP-2 represent a hot spot of binding to BRIA. The BMP-2, variant L51P was deficient in type I receptor binding only, whereas its, overall structure and its binding to type II receptors and modulator, proteins, such as noggin, were unchanged. Thus, the L51P substitution, converts BMP-2 into a receptor-inactive inhibitor of noggin. These results, are relevant for other proteins of the TGF-beta superfamily and provide, useful clues for structure-based drug design.
Bone morphogenetic protein-2 (BMP-2) and other members of the TGF-beta superfamily regulate the development, maintenance and regeneration of tissues and organs. Binding epitopes for these extracellular signaling proteins have been defined, but hot spots specifying binding affinity and specificity have so far not been identified. In this study, mutational and structural analyses show that epitopes of BMP-2 and the BRIA receptor form a new type of protein-protein interface. The main chain atoms of Leu 51 and Asp53 of BMP-2 represent a hot spot of binding to BRIA. The BMP-2 variant L51P was deficient in type I receptor binding only, whereas its overall structure and its binding to type II receptors and modulator proteins, such as noggin, were unchanged. Thus, the L51P substitution converts BMP-2 into a receptor-inactive inhibitor of noggin. These results are relevant for other proteins of the TGF-beta superfamily and provide useful clues for structure-based drug design.


==Disease==
==Disease==
Known diseases associated with this structure: Cowden-like syndrome OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=601299 601299]], Juvenile polyposis syndrome, infantile form OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=601299 601299]], Polyposis syndrome, hereditary mixed, 2 OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=601299 601299]], Polyposis, juvenile intestinal OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=601299 601299]]
Known diseases associated with this structure: HFE hemochromatosis, modifier of OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=112261 112261]], Juvenile polyposis syndrome, infantile form OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=601299 601299]], Polyposis syndrome, hereditary mixed, 2 OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=601299 601299]], Polyposis, juvenile intestinal OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=601299 601299]]


==About this Structure==
==About this Structure==
1REW is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Active as [http://en.wikipedia.org/wiki/Non-specific_serine/threonine_protein_kinase Non-specific serine/threonine protein kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.11.1 2.7.11.1] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1REW OCA].  
1REW is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Active as [http://en.wikipedia.org/wiki/Non-specific_serine/threonine_protein_kinase Non-specific serine/threonine protein kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.11.1 2.7.11.1] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1REW OCA].  


==Reference==
==Reference==
Line 19: Line 18:
[[Category: Protein complex]]
[[Category: Protein complex]]
[[Category: Keller, S.]]
[[Category: Keller, S.]]
[[Category: Mueller, T.D.]]
[[Category: Mueller, T D.]]
[[Category: Nickel, J.]]
[[Category: Nickel, J.]]
[[Category: Sebald, W.]]
[[Category: Sebald, W.]]
[[Category: Zhang, J.L.]]
[[Category: Zhang, J L.]]
[[Category: tgf-beta fold; bria-fold; 3-finger toxin fold]]
[[Category: tgf-beta fold; bria-fold; 3-finger toxin fold]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 19:02:34 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 14:50:06 2008''

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA